PlainRecalls
FDA Drug Critical Class I Terminated

Anagrelide Capsules, USP 1 mg, 100 capsules, Rx only, Manufactured in India for: Torrent Pharma Inc., Basking Ridge, NJ 07920 NDC 13668-462-01

Reported: December 9, 2020 Initiated: November 25, 2020 #D-0166-2021

Product Description

Anagrelide Capsules, USP 1 mg, 100 capsules, Rx only, Manufactured in India for: Torrent Pharma Inc., Basking Ridge, NJ 07920 NDC 13668-462-01

Reason for Recall

Failed Dissolution Specifications

Details

Recalling Firm
Torrent Pharma Inc
Units Affected
2496 Bottles
Distribution
Nationwide USA and Puerto Rico
Location
Levittown, PA

Frequently Asked Questions

What product was recalled?
Anagrelide Capsules, USP 1 mg, 100 capsules, Rx only, Manufactured in India for: Torrent Pharma Inc., Basking Ridge, NJ 07920 NDC 13668-462-01. Recalled by Torrent Pharma Inc. Units affected: 2496 Bottles.
Why was this product recalled?
Failed Dissolution Specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on December 9, 2020. Severity: Critical. Recall number: D-0166-2021.